Upperton Files MHRA Approval for 7,000 sq. ft Sterile CDMO Manufacturing Facility
Upperton has submitted an application to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for approval of a 7,000 sq. ft sterile manufacturing facility in Nottingham, UK. The submission follows the completion of aseptic process simulation validation batches carried